重组大鼠Hrg蛋白

¥3400-14900
伊艾博(EIAab)
湖北武汉
2022-08-17 16:13

伊艾博(武汉)科技股份有限公司

我要认领
伊艾博(武汉)科技股份有限公司
胡春晖
产品属性
产品说明
别名:Histidine-proline-rich glycoprotein,HPRG,Histidine-rich glycoprotein 1,HRG1,Hrg1

序列号:Q99PS8

来源:E.coli

种属:Rat

标签:His

纯度:>9% by SDS-PAGE

浓度:Reconstitution Dependent

形态:Liquid

应用:ELISA、Western Blot、Antigen Protein

存储缓冲液:50mM NaH2PO4, 500mM NaCl Buffer with 500mM Imidazole, 10%glycerol(PH8.0)

存储:Store at -20°C. (Avoid repeated freezing and thawing.)

通用注释
亚单元:Interacts with THBS1 (via the TSP type I repeats); the interaction blocks the antiangiogenic effect of THBS1 with CD36. Interacts with HPSE; the interaction is enhanced at acidic pH, partially inhibits binding of HPSE to cell surface receptors and modulates its enzymatic activity. Interacts (via the HRR domain) with TMP1; the interaction partially mediates the antiangiogenic properties of HRG. Interacts with kappa and lambda light chains of IgG molecules. Interacts with ATP5A1; the interaction occurs on the surface of T-cells and alters their cell morphology in concert with CONA. Binds IgG molecules containing kappa and lambda light chains and inhibits the formation of insoluble immunoglobulin complexes. Interacts with F12; the interaction, which is enhanced in the presence of zinc ions and inhibited by heparin-binding to HRG, inhibits factor XII autoactivation and contact-initiated coagulation (By similarity). Interacts with PLG (via its Kringle domains); the interaction tethers PLG to the cell surface and enhances its activation. Interacts (via the HRR domain) with TPM1; the interaction appears to contribute to the antiangiogenic properties of the HRR domain. Interacts with THBS2; the interaction blocks the antiangiogenic effect of THBS2 with CD36.
功能:Plasma glycoprotein that binds a number of ligands such as heme, heparin, heparan sulfate, thrombospondin, plasminogen, and divalent metal ions. Inhibits rosette formation. Acts as an adapter protein and implicated in regulating many processes such as immune complex and pathogen clearance, cell adhesion, angiogenesis, coagulation and fibrinolysis. Mediates clearance of necrotic cells through enhancing the phagocytosis of necrotic cells in a heparan sulfate-dependent pathway. This process can be regulated by the presence of certain HRG ligands such as heparin and zinc ions. Binds to IgG subclasses of immunoglobins containing kappa and lambda light chains with different affinities regulating their clearance and inhibiting the formation of insoluble immune complexes. Tethers plasminogen to the cell surface. Binds T-cells and alters the cell morphology. Modulates angiogenesis by blocking the CD6-mediated antiangiongenic effect of thrombospondins, THBS1 and THBS2.
亚细胞位置: Secreted

EIAab®
伊艾博(武汉)科技股份有限公司专注于生命科学领域的产品与技术研发,拥有基因重组、免疫层析、标记、抗体配对、包被等核心技术优势。主要自主研发产品:酶联免疫/化学发光试剂盒,多/单克隆抗体,重组蛋白(原核表达为主),807种原代细胞(iCell®品牌)及专用培养基等;技术服务:线上产品定制,基因克隆与表达/基因敲除,人/动物组织源的原代细胞分离、培养、复苏、STR检测分析等。公司业务还涉及生命科学相关信息化领域:蛋白aa序列及3D结构数据库(aa3D),样品检测资源库(SPDB),人工智能实验室(AI-Lab)等。





全球供应
EIAab具有自营进出口资格。 所有产品的制造和组装均严格按照EIAab制订的标准执行。 EIAab还在大力开展自主创新,逐步减少原料进口,降低生产成本,进一步降低大学和生命科学研究中心的科研经费。

EIAab® 技术
EIAab的办公地址和研发中心厂区位于中国武汉东湖高新技术开发区生物医药园区一期。 公司配备有超低温冷藏中心,血液采样和预处理中心以及实验动物养殖场。 EIAab员工至少拥有学士学位,大多数还拥有硕士学位和博士学位。 他们的专业涵盖了生命科学领域的各种相关专业,如医学免疫学,临床医学,药学,蛋白质组学,生物技术,农学,环境科学,生物信息学,IT编程语言等。


发展前景
21世纪,世界科学技术的重心已悄然转向生物技术和人工智能。生命科学已经成为了生物技术和生物医学工程技术的前沿和核心战场。 新技术层出不穷,应用前景广阔,生命科学几乎涉及到各个领域,这也促使了我们公司将成为一个活跃,开放和高技术的企业。



企业官网:www.eiaab.com.cn(可点击访问)